This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, C. A.
Right arrow Articles by Callister, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, C. A.
Right arrow Articles by Callister, S. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2002, p. 2070-2073, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2070-2073.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Reassessment of a Midwestern Lyme Disease Focus for Borrelia burgdorferi and the Human Granulocytic Ehrlichiosis Agent

Craig A. Jackson,1 Steven D. Lovrich,1* William A. Agger,1,2 and Steven M. Callister1,2

Microbiology Research Laboratory,1 Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, Wisconsin 546012

Received 27 September 2001/ Returned for modification 4 February 2002/ Accepted 8 March 2002

Previous studies from the late 1980s defined the risk of human Lyme disease by determining the prevalence of Borrelia burgdorferi infection in Ixodes scapularis ticks and Peromyscus sp. mice captured from areas around La Crosse, Wis. High percentages of B. burgdorferi-infected I. scapularis ticks and P. leucopus mice were common in areas located north of Interstate 90 but were not detected in areas south of this major east-west thoroughfare. In this study, we reevaluated the extent of B. burgdorferi infection. High percentages of mice captured from sites north of the interstate were still infected with B. burgdorferi. In addition, B. burgdorferi was recovered from 12 (67%) of 18 mice captured from a site well south of the highway. However, none of 104 mice or 713 I. scapularis ticks captured from the study sites were infected with Ehrlichia spp. The results confirmed the continued high risk for humans to contract infection with B. burgdorferi and the significant southward expansion of the area in which Lyme disease is endemic. In contrast, the risk of acquiring human granulocytic ehrlichiosis remains minimal despite the abundance of appropriate vector ticks and reservoir rodents.


* Corresponding author. Mailing address: Microbiology Research Laboratory, Gundersen Lutheran Medical Center, 1836 South Ave., La Crosse, WI 54601. Phone: (608) 782-7300, ext. 3743. Fax: (608) 791-6602. E-mail: sdlovric{at}gundluth.org.


Journal of Clinical Microbiology, June 2002, p. 2070-2073, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2070-2073.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • LaFleur, R. L., Dant, J. C., Wasmoen, T. L., Callister, S. M., Jobe, D. A., Lovrich, S. D., Warner, T. F., Abdelmagid, O., Schell, R. F. (2009). Bacterin That Induces Anti-OspA and Anti-OspC Borreliacidal Antibodies Provides a High Level of Protection against Canine Lyme Disease. CVI 16: 253-259 [Abstract] [Full Text]  
  • Jobe, D. A., Lovrich, S. D., Asp, K. E., Mathiason, M. A., Albrecht, S. E., Schell, R. F., Callister, S. M. (2008). Significantly Improved Accuracy of Diagnosis of Early Lyme Disease by Peptide Enzyme-Linked Immunosorbent Assay Based on the Borreliacidal Antibody Epitope of Borrelia burgdorferi OspC. CVI 15: 981-985 [Abstract] [Full Text]  
  • Lovrich, S. D., La Fleur, R. L., Jobe, D. A., Johnson, J. C., Asp, K. E., Schell, R. F., Callister, S. M. (2007). Borreliacidal OspC Antibody Response of Canines with Lyme Disease Differs Significantly from That of Humans with Lyme Disease. CVI 14: 635-637 [Abstract] [Full Text]